Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kelly Benante"'
Autor:
Oukseub Lee, Latifa A. Bazzi, Yanfei Xu, Erik Pearson, Minhua Wang, Omid Hosseini, Azza M. Akasha, Jennifer Nam Choi, Scott Karlan, Melissa Pilewskie, Masha Kocherginsky, Kelly Benante, Thomas Helland, Gunnar Mellgren, Eileen Dimond, Marjorie Perloff, Brandy M. Heckman-Stoddard, Seema A. Khan
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 171, Iss , Pp 116105- (2024)
Breast cancer prevention only requires local exposure of the breast to active drug. However, oral preventive agents entail systemic exposure, causing adverse effects that limit acceptance by high-risk women. Drug-delivery through the breast skin is a
Externí odkaz:
https://doaj.org/article/866b000bd0524b18baec1ef3a47518c6
Autor:
York E. Miller, Moumita Ghosh, Daniel T. Merrick, Brandi Kubala, Eva Szabo, Lisa Bengtson, Masha Kocherginsky, Irene B. Helenowski, Kelly Benante, Tia Schering, Jihye Kim, Hyunmin Kim, Duc Ha, Raymond C. Bergan, Seema A. Khan, Robert L. Keith
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionIloprost, a prostacyclin analog, has lung cancerpreventive activity in preclinical models and improved dysplasia in former smokers in a phase IIb trial. Oral iloprost is currently unavailable. We performed a phase Ib trial of inhaled ilop
Externí odkaz:
https://doaj.org/article/502903e34d9c4e43b8cf25ff8ca2f407
Autor:
Marc T. Goodman, Simon K. Lo, Dhiraj Yadav, Bechien U. Wu, Laith H. Jamil, Karl K. Kwok, Georgios I. Papachristou, Elham Afghani, Yunhee Choi-Kuaea, Richard T. Waldron, Christina Lombardi, Christie Y. Jeon, Irene B. Helenowski, Ellen Richmond, Kelly Benante, Aida Habtezion, Tia Schering, Seema A. Khan, Luz M. Rodriguez, Stephen J. Pandol
Publikováno v:
Pancreas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc9d19f0a6ead7f68064867097f797af
https://doi.org/10.1097/mpa.0000000000001955
https://doi.org/10.1097/mpa.0000000000001955
Autor:
Oukseub Lee, Xinlei Mi, Yanfei Xu, Luis Blanco, Azza M. Akasha, Kelly Benante, Shanshan Zhang, Carissa LaBoy, Thomas Helland, Melissa Pilewskie, Amy Degnim, Zahraa Al-Hilli, Amanda L. Amin, E Shelley Hwang, Joseph M. Guenther, Simon Steinar Hustad, Demirkan B. Gursel, Masha Kocherginsky, Gunnar Mellgren, Eileen Dimond, Marjorie Perloff, Brandy M. Heckman-Stoddard, Seema Khan
Publikováno v:
Cancer Research. 83:PD15-12
Background: Adjuvant oral tamoxifen (TAM) benefits women with DCIS, but toxicity concerns have limited its acceptance. Transdermal therapy with 4-hydroxy tamoxifen (4-OHT) gel applied to the breast skin is a possible solution. Previous pilot data sug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fe6d93bcf1a627be9145585638bf439
https://doi.org/10.1158/1538-7445.sabcs22-pd15-12
https://doi.org/10.1158/1538-7445.sabcs22-pd15-12